International Journal of Pharmacology and Clinical Sciences, 2022, 11, 2, 41-47.
DOI: 10.5530/ijpcs.2022.11.9
Published: June 2022
Type: Review Article
Authors: Yousef Ahmed Alomi, Amal Hassan Al-Najjar, Maha Hussein Almadany, and Abeer Hussin
Almasoudi
Author(s) affiliations:
Yousef Ahmed Alomi*, BSc.Pharm, MSc. Clin Pharm, BCPS, BCNSP, DiBA, CDE Critical Care Clinical Pharmacists, TPN Clinical Pharmacist, Freelancer Business Planner, Content Editor, and Data Analyst, Riyadh, Saudi Arabia.
Amal Hassan Al-Najjar, BSc, MSc, Drug and Poison Information Center, Security Forces Hospitals, Riyadh, Saudi Arabia.
Maha Hussein Almadany, BSc. Pharm, Health Care Quality Management Professional Diploma (HCQM), Pharmacy Quality Department, King Salman bin Abdulaziz Medical City, Al Madina Al Monwarah, Saudi Arabia.
Abeer Hussin Almasoudi, BSc.Pharm, Director, Administration of Research and Studies, Ministry of Health, Tabuk, Saudi Arabia.
Abstract
Objectives: This study illustrates the Research policy of narrative review design in pharmacy practice as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Literature researched specific research policies and procedures in pharmacy practice using a variety of databases, including PubMed, Medline, and Google Scholar. The period covered for the search is from the 1960s to October 2021. The terms used are in English and encompass systemic reviews, meta-analyses, narrative reviews, and guidelines. The search term includes all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital and pharmacy practice. The committee of narrative review pharmacy research committee was formed. It consisted of numerous expert members, including clinical pharmacists, drug information pharmacists, and clinical research specialists. A member drafted the policy’s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The topic emphasizes the Pharmacy Research policy of the narrative review model. Results: Pharmacy Research’s policy on the narrative review model in pharmaceutical care services covered various topics, including the advantages and disadvantages of narrative review, the steps involved in conducting a drug review model, the steps involved in conducting disease drug therapy, and the steps involved in operating a new project in pharmacy practice. Conclusion: The narrative review policy for pharmacy research is a new initiative within pharmacy research. The narrative review pharmacy policy facilitates communication between healthcare professionals regarding recent drug reviews and disease-specific drug therapy. Besides, the pharmacy is embarking on a new endeavor with a healthcare organization. Therefore, all narrative review models in pharmacy research policy are highly recommended for the careers of Saudi Arabian pharmaceutical professionals.
Keywords: Disease drug therapy, Drug review, Narrative review, New project, Pharmacy, Policy, Research, Saudi Arabia